TheFishSite.com - news, features, articles and disease information for the fish industry

AQUAVAC® Strep Sa


Species
Diseases Treated
Environment

AQUAVAC® Strep Sa

Vaccine for the active immunization of susceptible fish species to reduce mortality and disease due to Streptococcosis caused by Streptococcus agalactiae

Key Features

  • Contains inactivated cultures of Streptococcus agalactiae specifically selected for protection against S. agalactiae biotype 2

  • Demonstrated cross protection against S. agalactiae Biotype 2 strains from both Asian and Latin American Tilapia producing countries

  • Oil adjuvanted injection vaccine

  • Part of the Strep Control: Your Tilapia Health program

Key Benefits

  • Reduction in mortality and disease due to Streptococcosis caused by Streptococcus agalactiae

  • Duration of immunity demonstrated for at least 30 weeks after a single vaccination

  • Significant improvement in food conversion ratio (FCR) demonstrated in vaccinated fish under disease pressure.

< More vaccines

This website contains information on veterinary pharmaceutical and biological products based on international registration dossiers. The site may refer to products that are either not available in your country or are marketed under a different tradename. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.


Our Sponsors

Partners



Sustainable Aquaculture Modular Courses AVAILABLE NOW - University of St Andrews

Seasonal Picks

Know Your Freshwater Fishes - 5m Books.com

Aquacullture Webinars from TheFishSite - Sign Up Now